Company / Total Assets
NewAmsterdam Pharma Co N.V. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$769.3M
FY2025
5-year range
$347.1M / $864.6M
FY2022-FY2025
Trend
-11.0%
vs FY2024
Sector context
#101 of 215
Health Care
What the data says
At $769M, NewAmsterdam Pharma Co N.V.'s total assets ranks #101 of 215 in the Health Care sector. Improved from $347M to $769M over the past 2 years.
Based on SEC 10-K filings.
$769M in FY2025 with a 3-year CAGR of +17.1%.
Improved from $347M to $769M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#101 of 215 in Health CareTop 47% of 215This company $769.3M Sector average $7.5B
▼
-89.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, total assets decreased 11.0% year-over-year.
- Ranks #101 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $769.3M | -11.0% |
| FY2024 | $864.6M | +149.1% |
| FY2023 | $347.1M | -27.5% |
| FY2022 | $478.5M | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026